Hadassah Medical Center Professor Elected "Director at Large" for Prestigious Radiopharmaceutical Society
Prof. Eyal Mishani, who established Hadassah's Cyclotron Radiochemistry Unit, was elected to serve as "Director at Large" on the five-member Executive of the Society of Radiopharmaceutical Sciences (SRS).
Prof. Mishani is a member of the editorial board of two leading scientific magazines and has won many awards for his scientific work. Hadassah's Cyclotron Unit is a radiopharmaceutical center which functions within the Medical Center's Research and Development Division in collaboration with the Department of Nuclear Medicine. Its main objective is to synthesize and produce new radio-labeled molecules for the diagnosis and evaluation of various disease states using Positron Emission Tomography (PET) imaging. The molecules are used by Hadassah as well as other major PET centers around Israel.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>